{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-037412","form_type":"8-K","ticker":"CC","cik":"0001627223","company_name":"Chemours Co","filed_at":"2024-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.858261+00:00","generated_at":"2026-06-04T06:13:13.226863+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Chemours Q4 adjusted EPS $0.31 vs $0.00 YoY; full year net loss $238M on $764M litigation charges","bullets":["Q4 2023 net sales $1.4B (+2% YoY); full year net sales $6.0B (-11% YoY).","Q4 net loss $18M ($0.12 loss/diluted); adjusted net income $46M ($0.31 diluted EPS).","Full year net loss $238M ($1.60 loss/share); adjusted net income $425M ($2.82 EPS) vs $738M prior.","Adjusted EBITDA Q4 $176M vs $120M prior; full year $1.0B vs $1.4B, impacted by $89M/$764M litigation charges.","Segment: TT +7%, TSS +17%, APM -15%; CEO cites destocking and progress on legacy environmental matters."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-037412","json":"https://secwatch.observer/filing/0000950170-24-037412.json","markdown":"https://secwatch.observer/filing/0000950170-24-037412.md","text":"https://secwatch.observer/filing/0000950170-24-037412.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1627223/000095017024037412/0000950170-24-037412-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1627223/000095017024037412/cc-20240327.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T06:13:13.226863+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2cecb0ea4c0b5498fd92d14af62127170d07d1d9","claim":"Chemours Co reported fourth quarter and full year 2023 results: revenue Net Sales of $1.4 billion, net income Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share, EPS Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share.","evidence_excerpt":"The Chemours Company Reports Fourth Quarter and Full Year 2023 Results Wilmington, Del., March 27, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the fourth quarter and full year 2023. Key Fourth Quarter 2023 Results • Net Sales of $1.4 billion, up 2% year-over-year • Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1627223/000095017024037412/0000950170-24-037412-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and full year 2023"},{"label":"Revenue","value":"Net Sales of $1.4 billion"},{"label":"Net income","value":"Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share"},{"label":"EPS","value":"Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}